iRGD peptide 1 TFA

iRGD peptide 1 TFA, a paramount biomedical innovation, embodies incredible potential in cancer therapeutics. This exquisitely engineered peptide elucidates extraordinary proficiency in tumor targeting, revolutionizing drug transportation to malignant cells. Its profound impact on drug infiltration into tumor microenvironment burgeons therapeutic efficacy, effectively augmenting the potency of anticancer agents. With unparalleled benefits, iRGD peptide 1 TFA emerges as a groundbreaking solution towards combating cancer.

Online Inquiry

Specification Technical Data Related Products Featured Products Customer reviews and Q&A Useful Tools Publications

CAT#	GR2188
M.F/Formula	C37H60F3N13O16S2
M.W/Mr.	1064.08
Appearance	Solid

CAT#	Product Name	Inquiry
GR2196	DfTat	Inquiry
GR2108	Maurocalcine	Inquiry
GR2225	PKC β pseudosubstrate TFA	Inquiry
GR2170	activable cell-penetrating peptide (ACCP)	Inquiry
GR2216	SynB1	Inquiry

CAT#	Product Name	M.W	Molecular Formula	Inquiry
10-101-20	Goserelin Acetate	1269.43	C59H84N18O14	Inquiry
10-101-59	Liraglutide	3751.2	C172H265N43O51	Inquiry
R1574	Octreotide	1019.24	C₄₉H₆₆N₁₀O₁₀S₂	Inquiry
10-101-139	Myrcludex B			Inquiry
10-101-285	Teduglutide	3752.08	C164H252N44O55S	Inquiry
R1847	Sermaglutide	4114	C187H291N45O59	Inquiry
R1961	Carbetocin	988.2	C45H69N11O12S	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.